Clinical Laboratory Tests Market Report 2025

The clinical laboratory tests market size has grown rapidly in recent years. It will grow from $134.61 billion in 2024 to $150.29 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising demand for early disease detection, increasing healthcare expenditure, growing awareness of routine health checkups, expanding adoption of personalized medicine, heightened physician reliance on lab-based evidence, and the expansion of public health screening programs.

The clinical laboratory tests market size is expected to see rapid growth in the next few years. It will grow to $230.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to rising adoption of preventive healthcare, increasing use of molecular diagnostics, growing prevalence of lifestyle-related diseases, rising demand for home-based testing, and increasing incidence of chronic conditions. Major trends during this period include enhanced integration of AI in laboratory testing, innovations in point-of-care diagnostics, integration with digital health platforms, advancements in laboratory automation systems, and expanded use of biomarkers in diagnostics.

The rising obesity levels are expected to propel the growth of the clinical laboratory tests market going forward. Obesity levels indicate the prevalence of excess body fat in a population, commonly measured using body mass index (BMI) criteria. The increase in obesity is primarily driven by sedentary lifestyles, where reduced physical activity leads to an imbalance between calorie intake and expenditure, causing fat accumulation. Clinical laboratory tests support obesity management by identifying underlying health conditions, such as metabolic disorders, hormonal imbalances, or nutrient deficiencies, and by monitoring obesity-related risk factors, including blood glucose, cholesterol, and liver function, to guide personalized treatment plans. For instance, in May 2024, the Office for Health Improvement & Disparities, a UK-based government agency, reported that 64% of adults aged 18 and over in England were estimated to be overweight or living with obesity in 2022-2023. Therefore, rising obesity levels are driving the growth of the clinical laboratory tests market.

Prominent companies in the market are focusing on innovations such as direct-to-consumer genetic testing to advance personalized healthcare, increase patient engagement, and broaden access to diagnostics. Direct-to-consumer genetic testing allows individuals to request genetic tests without a physician’s referral, providing insights into health risks, ancestry, or genetic traits through DNA analysis. For example, in July 2023, Quest Diagnostics Inc., a US-based medical laboratory company, introduced genetic insights testing that examines 36 genes using next-generation sequencing to evaluate risks for nearly two dozen inheritable conditions. The test delivers tailored health reports with physician oversight and complimentary genetic counseling, empowering individuals to proactively manage their health risks.

In December 2024, Wildcat DX LLC, a US-based healthcare services company, acquired Navis Clinical Laboratories Inc. to expand diagnostic capabilities and accelerate growth. The acquisition aims to enhance Navis’s operational capabilities, leverage Wildcat DX’s business network, and achieve combined annual revenues of approximately $200 million. Navis Clinical Laboratories Inc. is a US-based company providing a wide range of clinical laboratory tests.

Major players in the clinical laboratory tests market are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, LabCorp, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Charles River Laboratories International Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN NV, Exact Sciences Corporation, Cepheid Inc., OPKO Health Inc., Myriad Genetics Inc., ARUP Laboratories, Guardant Health Inc., Thyrocare Technologies Limited, and Unilabs Diagnostics AB.

North America was the largest region in the clinical laboratory tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical laboratory tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical laboratory tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Clinical laboratory tests refer to diagnostic analyses conducted on samples such as blood, urine, tissue, or other bodily fluids to detect, diagnose, monitor, or prevent diseases. These tests provide essential information that helps physicians make informed clinical decisions and are routinely employed in health checkups, disease screening, and treatment monitoring.

The primary types of clinical laboratory tests include complete blood count (CBC), hemoglobin or hematocrit testing, basic metabolic panel, blood urea nitrogen and creatinine testing, electrolyte testing, HbA1c testing, comprehensive metabolic panel, liver panel, renal panel, and others. A complete blood count evaluates levels of different blood cells to detect infections, anemia, and other hematological disorders. These tests are offered through hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories, and are applied in areas such as parasitology, virology, hematology, toxicology, immunology, histopathology, and urinalysis, serving end users including central laboratories, hospitals, and primary care clinics.

The clinical laboratory tests market research report is one of a series of new reports that provides clinical laboratory tests market statistics, including the clinical laboratory tests industry's global market size, regional shares, competitors with the clinical laboratory tests market share, detailed clinical laboratory tests market segments, market trends and opportunities, and any further data you may need to thrive in the clinical laboratory tests market. This clinical laboratory tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical laboratory tests market includes revenues earned by entities by providing services such as routine and specialized lab testing services, and analytical support for disease detection and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.